Medical Devices Startups

Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation. The company's approach addresses early-stage egg development independent of hormonal processes, offering a potential solution for women who do not benefit from existing fertility treatments.

1 investor

NovaGo Therapeutics is a biotech company developing antibody-based therapeutics to promote nerve repair and recovery following spinal cord injury. The company's candidates are designed to enhance nerve regeneration and functional recovery, with Phase 1 clinical trials expected to begin in 2024.

1 investor

Novapep is an Australian-US biotech company developing G10, a polypeptide agonist that mimics activated protein C signaling to reduce inflammation. The company focuses on peptide-based therapeutics for inflammatory and infectious diseases.

1 investor

NovaResp develops respiratory technologies for the diagnosis and treatment of sleep apnea and sleep-disordered breathing, based on its cMAP technology. The company is led by a multidisciplinary team of respiratory therapists, scientists, physicians, and engineers.

1 investor

NovaSight develops eye-tracking software for detecting and managing myopia, primarily in children and teenagers. Its SaaS product creates real-time myopic blur on screens based on the user's gaze position and monitors visual health by alerting to eye fatigue or dry eye.

1 investor

Novaurum Biosciences develops nanotechnology-based coatings for medical devices and implants, using atomic layer deposition and a proprietary cell-based coating to improve biocompatibility, reduce infection, and support tissue integration. It serves medical device manufacturers, working at the intersection of microbiology and materials science.

1 investor

Novian Health develops Novilase, a minimally invasive laser ablation system for treating breast tumors (both malignant and benign) as an alternative to surgery. The device has received FDA 510(k) clearance for benign breast tumors and CE Mark approval in Europe, with clinical trials underway for early-stage breast cancer treatment.

1 investor

Novidan manufactures hearing aids, including the NoviOne RIC Wireless, an FDA-registered over-the-counter device with wireless connectivity and audio streaming. The company provides turnkey manufacturing solutions and customization services for hearing aid products.

1 investor

Novilytic develops a simplified analytical testing system using a single HPLC instrument with fluorescence detection and proprietary Proteometer Kit to replace multiple instruments and personnel traditionally required for R&D analytical work in chemistry.

1 investor

NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries. The device has received FDA Breakthrough Device Designation and supports the growth of new meniscus-like tissue as it resorbs.

1 investor

Novo Protein supplies GMP-grade mRNA enzymes, reagents, and diagnostic materials for biopharmaceutical research and production, including reagents for in vitro transcription, molecular diagnostics, gene editing, and immunoassay development.

1 investor

Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury. The company focuses on drug discovery for neurological conditions such as neurodegeneration and cognitive decline.

1 investor

NOVUSON develops biomedical instrumentation and medical devices, serving healthcare organizations and clinical environments. The company focuses on innovative medical technology across biomechanics, tissue engineering, and surgical device platforms.

1 investor

NovusTX Devices develops therapeutic ultrasound technology for clinical medical applications, particularly focusing on minimally invasive brain therapies using HIFU (high-intensity focused ultrasound). The company emerged from research collaboration at the Thunder Bay Regional Health Research Institute and the University of Calgary.

1 investor

Nowwell is a company driving innovation in urology through research and product development. The organization brings together expertise in clinical science, product development, quality assurance, and strategy.

1 investor

Noxon develops OCIAN, a non-invasive, skin-worn muscle-computer interface that decodes myoelectric signals and modulates muscle and nerve activity to track neuromuscular health and enable movement coordination and interface control. The system pairs a wearable electronic unit with a cloud platform ("OCIAN Hub") that transfers bidirectional signals between muscles and software.

1 investor

Nsight Health provides remote patient care using nursing staff and proprietary technology to monitor, predict, and prevent adverse health events, working through fee-for-service and at-risk contracts to lower care costs and improve outcomes. It serves patients across the United States, with a focus on underserved communities.

1 investor

A surgical performance analytics platform that collects intraoperative data to provide operating room teams with efficiency metrics, case costing, and quality benchmarking to support clinical and operational decision-making in hospitals.

1 investor

NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development. The company has won maternal and infant health innovation and startup investment competitions in Ireland.

1 investor

Nuada makes the Exo Glove, a wearable exoskeleton glove with a bracelet-based mechanical support system and artificial tendons that enhance hand grip and hold objects up to 20 kg without active effort. It targets people with hand weakness from injuries or conditions such as stroke, spinal cord injuries, and arthritis, as well as professionals performing repetitive gripping tasks.

1 investor

Nucleo automates CT scan analysis for oncology care, providing AI-powered tools for tumor lesion sizing, body composition assessment, and lesion classification to support clinical workflows in hospitals.

1 investor

Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment. The platform serves clinical departments across Europe and the US.

1 investor

Nueclear Healthcare Limited is a diagnostic network operating PET-CT centres across major Indian cities, offering advanced imaging technologies for cancer detection, staging, and monitoring. The company manufactures medical cyclotron units that produce radioactive biomarkers required for diagnostic scanning.

1 investor

NuEyes develops smart glasses and digital loupes incorporating augmented reality and 3D stereoscopic vision technology for individuals with low vision and medical professionals. The company serves both the medical precision and consumer accessibility markets through wearable assistive technology.

1 investor